BML Investment Partners, L.P. 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-19 4:29 pm Purchase | 2024-03-18 | 13G | CYTEIR THERAPEUTICS INC CYTT | BML Investment Partners, L.P. | 3,818,464 10.600% | 348,456 (+10.04%) | Filing |
| 2024-02-07 1:40 pm Purchase | 2023-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | BML Investment Partners, L.P. | 3,470,008 9.600% | 734,035 (+26.83%) | Filing |
| 2023-01-26 4:01 pm Purchase | 2023-01-20 | 13G | CYTEIR THERAPEUTICS INC CYTT | BML Investment Partners, L.P. | 2,735,973 7.700% | 2,735,973 (New Position) | Filing |